TNM staging of neoplasms of the endocrine pancreas: Results from a large international cohort study

Journal of the National Cancer Institute

Volumn 104, Issue 10, 2012, Pages 764-777

  Rindi, G ^a   Falconi, M ^b   Klersy, C ^c   Albarello, L ^d   Boninsegna, L ^b   Buchler, M W ^e   Capella, C ^f   Caplin, M ^g   Couvelard, A ^h   Doglioni, C ^c   Delle Fave, G ^j   Fischer, L ^d   Fusai, G ^k   De Herder, W W ^l   Jann, H ^m   Komminoth, P ⁿ   De Krijger, R R ^l   La Rosa, S ^o   Luong, T V ^k   Pape, U ^l   Perren, A ^p   Ruszniewski, P ⁱ   Scarpa, A ^b   Schmitt, A ^o   Solcia, E ^q   Wiedenmann, B ^l   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h Department of Pathology ^*  (Italy)

ⁱ BEAUJON HOSPITAL   (France)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k ROYAL FREE HOSPITAL   (United Kingdom)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁿ TRIEMLI HOSPITAL   (Switzerland)

^o OSPEDALE DI CIRCOLO   (Italy)

^p UNIVERSITY OF BERN   (Switzerland)

^q UNIVERSITY OF PAVIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EUROPEAN NEUROENDOCRINE TUMOR SOCIETY CANCER STAGING; FEMALE; FOLLOW UP; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNATIONAL UNION FOR CANCER CONTROL AMERICAN JOINT CANCER COMMITTEE WORLD HEALTH ORGANIZATION CANCER STAGING; MAJOR CLINICAL STUDY; MALE; PANCREATIC NEUROENDOCRINE TUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; OBSERVER VARIATION; ODDS RATIO; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 84861312666     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs208     Document Type: Article

References (33)

1. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063- 3072.
2. Modlin IM, Moss SF, Chung DC, et al. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008;100(18):1282-1289.
3. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395-401.
4. Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. 7th ed. Bognor Regis, UK: Wiley Blackwell; 2009.
5. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. New York, NY: Springer; 2010.
6. Bosman F, Carneiro F, Hruban RH, et al. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.
7. Ekeblad S, Skogseid B, Dunder K, et al. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008;14(23):7798-7803.
8. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 2008;95(5):627-635.
9. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol. 2009;40(1):30-40.
10. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113(2):256-265.
11. Zerbi A, Falconi M, Rindi G, et al. Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol. 2010;105(6):1421-1429.
12. Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol. 2010;23(6):824-833.
13. Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205(4):558-563.
14. Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29(22):3044-3049.
15. Kloppel G, Rindi G, Perren A, et al. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Archiv. 2010;456(6):595-597.
16. Rossi G, Nannini N, Mengoli MC, et al. Neuroendocrine tumors: what staging system? Am J Surg Pathol. 2010;34(8):1228-1230.
17. Rindi G, Arnold R, Capella C, et al. Nomenclature and classification of digestive neuroendocrine tumours. In: Bosman F, Carneiro F, Hruban RH, et al., eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010:10-12.
18. Solcia E, Klöppel G, Sobin LH. Histological Typing of Endocrine Tumours. 2nd ed. New York, NY: Springer-Verlag; 2000.
19. Newson RB. Comparing the predictive powers of survival models using Harrell's C or Somers' D. Stata J. 2010;10(3):339-358.
20. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387.
21. Akaike H. A new look at the statistical model identification. IEEE Trans Auto Cont. 1974;19(6):716-723.
22. Quirke P, Cuvelier C, Ensari A, et al. Evidence-based medicine: the time has come to set standards for staging. J Pathol. 2010;221(4):357-360.
23. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61-72.
24. Klimstra DS, Arnold R, Capella C, et al. Neuroendocrine neoplasms of the pancreas. In: Bosman F, Carneiro F, Hruban RH, et al., eds. WHO Classification of Tumours. Lyon, France: IARC; 2010:322-326.
25. Rindi G, de Herder WW, O'Toole D, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors: why such guidelines and how we went about It. Neuroendocrinology. 2006;84(3):155-157.
26. Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010;39(6):735-752.
27. Oberg K, Jelic S. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(suppl 2):ii104-ii105.
28. Bettini R, Boninsegna L, Mantovani W, et al. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol. 2008;19(5):903-908.
29. Yao JC, Rindi G, Evans DB. Pancreatic neuroendocrine tumors. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 9th ed. Philadelphia, PA: Wolters-Kluwer/Lippincott Williams and Wilkins; 2011:1489-1502.
30. Missiaglia E, Dalai I, Barbi S, et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2010;28(2):245-255.
31. Solcia E, Capella C, Klöppel G. Tumours of the Pancreas. 3rd Series ed. Washington, DC: Armed Force Institute of Pathology; 1997.
32. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. 4th Series ed. Washington, DC: The American Registry of Pathology and the Armed Force Institute of Pathology; 2007.
33. Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol. 2012;8(1):54-64.